Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adam Mandel

Orthopaedic Surgery Little River, SC Doctor of Osteopathy

NPI 1942410048 CMS profile 133153

3980 Highway 9 E Ste 200, Little River, SC 29566

Open in the dashboard

General payments

$17,959

139 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adam Mandel of Little River, SC is reported in the CMS Open Payments database as having received $17,959 across 139 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,231 34
2024 General $2,601 27
2023 General $1,839 15
2022 General $4,061 21
2021 General $762 8
2020 General $995 19
2019 General $2,470 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Mandel
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Adam Mandel were reported at $5,231. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Adam Mandel Orthopaedic Surgery median Middle half National median
2019 $2,470 $644 $140–$2,844 $163
2020 $995 $312 $75–$1,860 $114
2021 $762 $520 $117–$2,495 $132
2022 $4,061 $598 $128–$2,731 $149
2023 $1,839 $461 $128–$2,264 $160
2024 $2,601 $497 $134–$2,475 $164
2025 $5,231 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $7,987 64 payments
  2. Peerless Surgical Inc. $4,363 17 payments
  3. Treace Medical Concepts, Inc. $3,857 18 payments
  4. Stryker Corporation $754 11 payments
  5. Flexion Therapeutics, Inc. $346 11 payments
  6. DePuy Synthes Sales Inc. $256 4 payments
  7. Medline Industries, Inc. $115 2 payments
  8. Zimmer Biomet Holdings, Inc. $74 1 payment
  9. Solventum Corporation $74 3 payments
  10. Medtronic, Inc. $36 2 payments
  11. Other $99 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $11,090 34 payments
  2. Food and Beverage $4,009 102 payments
  3. Education $2,860 3 payments
Products named General payments · program years 2019–2025
  1. LAPIPLASTY SYSTEM 1 $1,748 5 payments
  2. LAPIPLASTY SYSTEM Foot And Ankle $1,435 7 payments
  3. Lapiplasty System Y $572 3 payments
  4. MEDLINE UNITE $462 8 payments
  5. INFINITY ADAPTIS $461 6 payments
  6. Zilretta $346 11 payments
  7. INBONE $243 3 payments
  8. NA $215 2 payments
  9. DISTAL EXTREMITIES IMPLANTS FRACTURE MANAGEMENT ANKLE FRACTURE $214 2 payments
  10. SALVATION $161 1 payment
  11. Other $1,265 31 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

396

Median for Orthopedic Surgery: 203

Drug cost

$1,811

Median for Orthopedic Surgery: $1,433

Branded share of claims

3.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Doxycycline Monohydrate Generic 44 $326
Oxycodone Hcl Generic 81 $289
Cephalexin Generic 95 $253
Clindamycin Hcl Generic 33 $253
Methylprednisolone Generic 37 $208
Celecoxib Generic 14 $197
Gabapentin Generic 37 $159
Doxycycline Hyclate Generic 11 $60
Tramadol Hcl Generic 31 $44
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 13 $23

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 106 billing codes

Paid by Medicare

$148,050

Of which drugs: $2,225

Medicare patients

533

Average age 73

Services billed

2,467

333 women, 200 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 70%
Diabetes 27%
Ischemic heart disease 24%
Depression 22%
Chronic kidney disease 21%
Atrial fibrillation 20%
Osteoporosis 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 122 438 $2,225

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

139 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record